Navigation Links
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Date:6/9/2009

SAN CARLOS, Calif., June 9 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the promotion of Lorianne Masuoka, M.D. to the position of Chief Medical Officer. Dr. Masuoka reports to Nektar's Senior Vice President, Drug Development and Chief Drug Development Officer, Randall Moreadith, M.D., Ph.D.

Dr. Masuoka has over 15 years of experience in clinical research and development. As Chief Medical Officer, she will be instrumental in helping to develop Nektar's clinical development strategy while continuing to oversee all clinical development functions, including Clinical Operations, Clinical Pharmacology, Drug Safety, Biometrics and Data Management. Dr. Masuoka joined Nektar in August 2008 as Vice President of Clinical Development.

"Lorianne's extensive clinical experience and superb guidance of our clinical development and operations teams make her an outstanding choice for Chief Medical Officer," said Randall Moreadith, M.D., Ph.D., Senior Vice President, Drug Development and Chief Drug Development Officer of Nektar, "Since joining Nektar, she has been instrumental in building our Drug Development group and assembling an internal Biometrics and Data Management Group, as well as streamlining our clinical operations."

Prior to Nektar, Lorianne was Vice President of Clinical Development at Five Prime Therapeutics where she led the advancement of a number of protein and antibody therapeutics in the areas of oncology, immunology and metabolic disease. Prior to that, Lorianne held senior leadership positions at Chiron and Berlex, where she was instrumental in development of Betaseron(R) for relapsing forms of multiple sclerosis as well as numerous oncology programs.

Dr. Masuoka received her M.D. from the University of California, Davis, completed a Fellowship
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Nektar Therapeutics Reports First Quarter 2009 Financial Results
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
3. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
4. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
5. Nektar Announces Retirement of Irwin Lerner from Board of Directors
6. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
7. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
8. Nektar Therapeutics to Webcast R&D Day on November 12th
9. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
10. Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...1 /PRNewswire-Asia/ -- Shanghai ChemPartner, as th...ina-based Contract Research,Organization (CRO), to...Technology Fast 50 China, ranking 3rd on the list ...a. The award is a testament to ChemPartner,s outst.... , The results of the 2009 Deloitte Tech...
(Date:12/1/2009)...1 The Burrill Biotech Select Index...t in October. The Select,s gain of 4.5 percent mir...eral markets with the Dow up 6.5 percent and the N... in the final two trading days of the month despit...iday shopping and Dubai,s reported debt woes. ,...
(Date:12/1/2009)...ent Software agrees to migrate their Microsoft Dyn...ents) to Synergy Business Solutions to maintain qu... WA (PRWEB) December 1, 2009 -- Synergy Business S...soft Dynamics SL practice of Congruent Software, a...ve was necessary due to a change in Congruent Soft...
(Date:12/1/2009)...BEACH, California and AMSTERDAM, December 1 /PRNew...cer diagnostics, announced today that,Palmetto GBA...established,coding guidelines for the company,s Ma... breast cancer recurrence test, which has been rei...across the United States can now submit claims for...
Breaking Biology Technology:Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2
...enta,Incorporated (OTC Bulletin Board: GNTA) today... June 30, 2008. The Company recorded significant,m...lowing:, -- NDA amendment for Genasense(R) in CLL...asense in melanoma updated at EADO, -- Clinical h...axane,lifted by FDA, -- Pharmacokinetics of or...
...stretchable optoelectronics and biologically inspi...maging device, with a layout based on the human ey... Nature, researchers at the University of Illino...gh-performance, hemispherical "eye" camera using a...d electronics, configured in a stretchable, interc...
...r service revenue grows approximately 33% ... - Operating margin of 9.9% for the quarter,- Rec...atio of 1.56 for the ...Corporation (Nasdaq: PRXL ) today announced its f... Year ended June 30, 2008., For the three months ...
Other Biology Technology:Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 2Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 3Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 4Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 5Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 6Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 7Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 8Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 9Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 10Stretchable silicon camera next step to artificial retina 2PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 2PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 3PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 4PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 5PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 6PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 7PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 8PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 9PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 10PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 11PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 12PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 13PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 14
(Date:11/30/2009)... HIV research is the virus,s exquisite specialisat...raditional tools, like the humble lab mouse, can d...searchers writing in BioMed Central,s open access ...t on this problem by creating a mouse that has key...with HIV. , George Kassiotis, from the Division ...
(Date:11/30/2009)...rt published in the December 2009 print issue of T...type of control over their fertility that women ha...have found how and where androgenic hormones work ...nd male fertility. This opens a promising avenue f...overy also offers hope to those who cannot have ch...
(Date:11/30/2009)...ess and odorless radioactive gas that is produced ...oduct of uranium decay and is found in trace amoun...dwater as well as building materials, plants, anim...is expressed as the amount of radiation that would...iter of air; thus the units are picocuries per lit...
Breaking Biology News(10 mins):A reductionist approach to HIV research 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Weeds that reinvented weediness 9780 1ViroPharma to Present at Several Upcoming Healthcare Conferences 13834 1ViroPharma to Present at Several Upcoming Healthcare Conferences 13834 2Choco Milk Initiates Adventure Filled Mobile Tour That Teaches Children Nutrition Awareness 56143 1Choco Milk Initiates Adventure Filled Mobile Tour That Teaches Children Nutrition Awareness 56143 2Choco Milk Initiates Adventure Filled Mobile Tour That Teaches Children Nutrition Awareness 56143 3
...la, CA August 15, 2007) A prominent problem in AI... concentrate and perform normal movements. Scient... (Burnham) have discovered how HIV/AIDS disrupts t...rain, preventing new nerve cells from forming. Dr...d their colleagues uncovered a novel molecular mec...
...s have discovered a key protein in the toxic brain...drome (FXTAS), an inherited neurodegenerative diso... FXTAS, could help unravel the complex mechanisms ...to target the protein. The research will be publi... Fragile X tremor/ataxia syndrome was first recog...
...ty, Canada - An international team of scientists f... of Hull, Cardiff University) and Spain (Do ana Bi...closely related species of East African cichlid fi...undreds of species has puzzled evolutionary biolog...aptations which might explain why they do not inte...
Other Biology News:AIDS interferes with stem cells in the brain 2AIDS interferes with stem cells in the brain 3Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA 2Adaptation to parasites drive African fishes along different evolutionary paths 2
...yces griseolusthat inhibits protein synthesis. Act...ukaryote ribosomes. Reported to induce apoptosis i...mia cells, Jurkat cells, ventricular myocytes, and...ar signals and immediate early gene induction. Sel...
...ovides reagents and a protein standard for determi...cing agents and detergents. The RC DC protein assa...ts and standards sufficient for 500 standard assay...ml alkaline copper tartrate solution, 2 L dilute F...
Gelatin from bovine skin from Sigma-Aldrich
...t separation system using the asymmetric flow Fiel... integrates easily with Wyatts multi-angle light s...ar, as well as the Optilab DSP. The combined syste...ons of the particles/molecules separated by the AF...
Biology Products: